France / Français
Master Doctor Search: Nutrition - Fitness > Alzheimer
FDA Leaders, Advisory Panel Go Head-to-Head Over Aducanumab
FDA leaders and members of the advisory panel that recommended against approval of the controversial Alzheimer's drug aducanumab have gone head-to-head in two perspectives...
1 month ago - Medscape
Lifetime exposure to lead linked to greater dementia risk
A study published in the Journal of Alzheimer's Disease suggests that lead might play a role in the development of dementia. Researchers from the University of Toronto reported...
2 monthes ago - Natural News
Zero Benefit of Aducanumab for Alzheimer's Disease, Panel Rules
An influential independent panel unanimously voted that aducanumab offers no benefit for Alzheimer's, adding to growing skepticism from medical experts about this controversial...
2 monthes ago - Medscape
Contentious Alzheimer's Drug Likely to Get National Pay Plan
CMS said it is working toward a national Medicare coverage policy for the controversial Alzheimer's drug aducanumab. Insurers have suggested CMS limit coverage of the drug...
2 monthes ago - Medscape
FDA Head Calls for Inquiry Into Agency's Approval of Aducanumab
Following the US Food and Drug Administration's controversial approval of aducanumab for Alzheimer's, the head of the agency is now calling for a federal investigation into its...
2 monthes ago - Medscape - 6 articles
FDA Updates Label for Controversial Alzheimer's Drug Aduhelm
The new label emphasizes that the drug should only be initiated in patients with mild cognitive impairment as a result of Alzheimer's disease or mild dementia stage of...
2 monthes ago - Medscape - 3 articles
Chronic Stress, Genetics May Raise Alzheimer's Risk
Long-term stress and genetics may act through the hypothalamic-pituitary-adrenal axis to contribute to the development of Alzheimer's disease, new research suggests. Medscape...
2 monthes ago - Medscape
FDA approves controversial drug for use against Alzheimer's disease, despite evidence showing it doesn't work
The Food and Drug Administration recently approved a drug for Alzheimer's disease despite warnings from experts that the controversial treatment hasn't been shown to slow the...
2 monthes ago - Natural News - 2 articles
High Dietary Iron Has a Greater Impact on Brain Iron Homeostasis and Cognitive Function in Old Compared with Young C57BL/6J Male Mice
ABSTRACTBackgroundBrain iron accumulation is a feature of Alzheimer disease but whether a chronic dietary iron overload contributes to AD induction is unknown. We previously...
2 monthes ago - Nutrition
Alzheimer's Drug Approval an FDA Blunder? Our Readers Weigh In
Most Medscape readers responding to our poll disagree with approval of the prohibitively expensive Alzheimer's drug aducanumab and don't plan to prescribe it. Medscape Medical News
2 monthes ago - Medscape
Free Registration
The headlines of Master Doctor
Obesity does not increase risk for serious infection in biologic-treated IBD
Obesity was not associated with an increased risk for serious infection among patients with inflammatory bowel disease treated with biologics, according to research published...
Vanilla Bean Mini Sheet Cake from Trader Joe's PFAS “Forever Chemicals” Lab...
Does the Chantilly Cream Vanilla Bean Mini Sheet Cake from Trader Joe's have any indication of PFAS contamination in the food packaging? This is what you've been asking us to...
AP-NORC Poll on Community Support of Older Adults Finds Disparities in...
Overall, more people think their local area is doing a good job than a poor job meeting the needs of older adults when it comes to many services, including health care, healthy...
Strength Training for Bone Density: How Much Benefit Can You Expect?
If you're a woman over 50, you may be tempted to forgo strength training and stay physically active in other ways, like walking or cycling. However, these exercises aren't high...